Evidence map›Paper›PMID 38303079›Full record

ArticleImmunology2024

Abrogation and homeostatic restoration of IgE responses by a universal IgE allergy CTL vaccine-The three signal self/non-self/self (S/NS/S) theory.

Swey-Shen Chen, Hailan Zhang

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Swey-Shen ChenDepartment of Immunology and Inflammation, AAIIT LLC, San Diego, California, USA.ORCID 0000-0003-2508-7707
Hailan ZhangDepartment of Immunology and Inflammation, AAIIT LLC, San Diego, California, USA.
Inflammation Research Foundation · US

Funding

Broadly neutralizing(BN) pan-IgE supersite vaccine for allergic asthmaR44AI126680 · NIAID · IGE THERAPEUTICS, INC. · PI CHEN, SWEY-SHEN · 2017 to 2019
$2.6M
CTL for supertype natural IgE cytotoxic peptide (nECP) to guard against allergic asthmaR44AI122358 · NIAID · IGE THERAPEUTICS, INC. · PI CHEN, SWEY-SHEN · 2016 to 2018
$2.3M
NIAID NIH HHS R44 AI122358NIAID NIH HHS R44 AI126680NIH HHS 5R44AI122358NIH HHS 5R44AI126680
6 · The paper itself

Abstract

Natural IgE cytotoxic peptides (nECPs), which are derived from the constant domain of the heavy chain of human IgE producing B cells via endoplasmic reticulum (ER) stress, are decorated onto MHC class 1a molecules (MHCIa) as unique biomarkers for CTL (cytotoxic T lymphocyte)-mediated immune surveillance. Human IgE exhibits only one isotype and lacks polymorphisms; IgE is pivotal in mediating diverse, allergen-specific allergies. Therefore, by disrupting self-IgE tolerance via costimulation, the CTLs induced by nECPs can serve as universal allergy vaccines (UAVs) in humans to dampen IgE production mediated by diverse allergen-specific IgE-secreting B cells and plasma cells expressing surface nECP-MHCIa as targets. The study herein has enabled the identification of nECPs, A32 and SP-1/SP-2 nonameric natural peptides produced through the correspondence principle. Vaccination using nECP induced nECP-specific CTL that profoundly suppressed human IgE production in vitro as well as chimeric human IgE production in human IgE/HLA-A2.01/HLA-B7.02 triple transgenic rodents. Furthermore, nECP-tetramer-specific CTLs were found to be converted into CD4 Tregs that restored IgE competence via the homeostatic principle, mediatepred by SREBP-1c suppressed DCs. Thus, nECPs showed causal efficacy and safety as UAVs for treating categorically type I hypersensitivity IgE-mediated allergies. The applied vaccination concept presented provides the foundation to unify, integrate through a singular class of tetramer-specific TCR clonotypes for regulaing human IgE production. The three signal theory pertains to mechanisms of three cells underlying central tolerance (S), breaking self tolerance (NS) and regaining peripheral tolerance (S) via homeostasis concerning nECP as an efficacious and safe UAV to treat type I IgE-mediated hypersensitivity. The three signal theory impirically extended, may be heuritic for immuno-regulation of adaptive immune repertoire in general.

Indexed as

HypersensitivityVaccinesAllergensEpitopes, T-LymphocyteHomeostasisHumansImmunoglobulin EPeptidesT-Lymphocytes, CytotoxicAllergensEpitopes, T-LymphocyteImmunoglobulin EPeptidesVaccinesallergyantigens/peptides/epitopesasthmaTreg

Identifiers

PMID38303079
PMCPMC10987285
OpenAlexW4391480796

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.